Francis Chou Buys Valeant Pharmaceuticals International Inc, Teva Pharmaceutical Industries, Sells Nokia Oyj, Citigroup Inc

Aug 15, 2017

Investment company Francis Chou buys Valeant Pharmaceuticals International Inc, Teva Pharmaceutical Industries, sells Nokia Oyj, Citigroup Inc during the 3-months ended 2017-06-30, according to the most recent filings of the investment company, Chou Associates Management. As of 2017-06-30, Chou Associates Management owns 25 stocks with a total value of $319 million. These are the details of the buys and sells.

Added Positions: VRX, TEVA,
Reduced Positions: NOK, C,

For the details of Francis Chou's stock buys and sells, go to http://www.gurufocus.com/StockBuy.php?GuruName=Francis+Chou

These are the top 5 holdings of Francis Chou

Valeant Pharmaceuticals International Inc (VRX) - 3,053,843 shares, 16.64% of the total portfolio. Shares added by 29.74%
Berkshire Hathaway Inc (BRK.A) - 150 shares, 12.03% of the total portfolio.
JPMorgan Chase & Co (JPM.WS) - 626,347 shares, 9.92% of the total portfolio.
Wells Fargo & Co (WFC.WS) - 997,500 shares, 6.97% of the total portfolio.
Resolute Forest Products Inc (RFP) - 4,963,423 shares, 6.88% of the total portfolio.

Added: Valeant Pharmaceuticals International Inc (VRX)

Francis Chou added to the holdings in Valeant Pharmaceuticals International Inc by 29.74%. The purchase prices were between $8.51 and $17.31, with an estimated average price of $11.95. The stock is now traded at around $13.68. The impact to the portfolio due to this purchase was 3.81%. The holdings were 3,053,843 shares as of 2017-06-30.

Added: Teva Pharmaceutical Industries Ltd (TEVA)

Francis Chou added to the holdings in Teva Pharmaceutical Industries Ltd by 134.88%. The purchase prices were between $27.82 and $32.95, with an estimated average price of $30.94. The stock is now traded at around $17.08. The impact to the portfolio due to this purchase was 3.03%. The holdings were 505,000 shares as of 2017-06-30.

Reduced: Nokia Oyj (NOK)

Francis Chou reduced to the holdings in Nokia Oyj by 54.55%. The sale prices were between $5.17 and $6.55, with an estimated average price of $5.99. The stock is now traded at around $6.32. The impact to the portfolio due to this sale was -2.74%. Francis Chou still held 1,250,000 shares as of 2017-06-30.

Reduced: Citigroup Inc (C)

Francis Chou reduced to the holdings in Citigroup Inc by 24.39%. The sale prices were between $57.72 and $66.98, with an estimated average price of $61.27. The stock is now traded at around $68.12. The impact to the portfolio due to this sale was -2.02%. Francis Chou still held 310,000 shares as of 2017-06-30.

Here is the complete portfolio of Francis Chou. Also check out:

1. Francis Chou's Undervalued Stocks
2. Francis Chou's Top Growth Companies, and
3. Francis Chou's High Yield stocks
4. Stocks that Francis Chou keeps buying

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.